Both in Pharmaceuticals
NRX Pharmaceuticals vs TuHURA Biosciences
Over the past year NRXP returned −20.7% and HURA returned −5.2%; their daily moves had a correlation of 0.12.
NRXP −20.7% HURA −5.2%Growth of $1, one year, split-adjusted
| Metric | NRXP | HURA |
|---|---|---|
| Price | $2.49 | $2.18 |
| Market cap | $107.8M | $138.9M |
| Today | +3.75% | +8.46% |
| 1 month | −17.8% | +3.8% |
| 6 months | −15.3% | −7.2% |
| Year to date | −8.1% | +188.1% |
| 1 year | −21.0% | −3.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | 38.7% | — |
| Net margin | −1500.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 31.8× | — |
| Net cash | $26.3M | -$4.2M |
| Dividend yield | — | — |
| Volatility (60d) | 57.5% | 67.7% |
| Short % of float | 28.8% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).